<DOC>
	<DOCNO>NCT00502632</DOCNO>
	<brief_summary>The purpose study determine whether intrapleural treatment Dornase alfa plus Urokinase improve clinical outcome compare Urokinase alone child complicate parapneumonic effusion</brief_summary>
	<brief_title>Dornase Alfa Urokinase Kids With Pleural Empyema</brief_title>
	<detailed_description />
	<mesh_term>Empyema</mesh_term>
	<mesh_term>Empyema , Pleural</mesh_term>
	<criteria>Age &gt; 1 year &lt; 16 year Respiratory infection ( pneumonia lung abscess ) Effusion occupy least 1/3 hemithorax chest Xray Complicated effusion ( presence least one follow ) : Hyperechoic pleural fluid chest US scan Loculated collection chest US CT scan Purulent pleural fluid Positive culture Gram stain pleural fluid Non parapneumonic effusion Immunodeficiency Neurological impairment Suspected proven allergy Urokinase Dornase alfa Suspected documented bronchopleural fistula Impaired coagulation ( INR &gt; 2 ) , haemorrhage , high risk bleed Thoracic surgical procedure ( e.g . thoracoscopy , minithoracotomy ) already perform Chest drain insert since 6 day</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Pleural empyema</keyword>
	<keyword>Pleural effusion</keyword>
	<keyword>Dornase alfa</keyword>
	<keyword>Urokinase</keyword>
	<keyword>Children</keyword>
</DOC>